Cargando…
Changing trends in carrier screening for genetic disease in the United States
Genetic disease is the leading cause of infant death in the United States, accounting for approximately 20% of annual infant mortality. Advances in genomic medicine and technological platforms have made possible low cost, pan‐ethnic expanded genetic screening that enables obstetric care providers to...
Autores principales: | Nazareth, Shivani B., Lazarin, Gabriel A., Goldberg, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758394/ https://www.ncbi.nlm.nih.gov/pubmed/26138560 http://dx.doi.org/10.1002/pd.4647 |
Ejemplares similares
-
Genetic Counselors’ Perspectives and Practices Regarding Expanded Carrier Screening after Initial Clinical Availability
por: Lazarin, Gabriel A., et al.
Publicado: (2016) -
Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples
por: Ghiossi, Caroline E., et al.
Publicado: (2017) -
Clinical utility of expanded carrier screening: results-guided actionability and outcomes
por: Johansen Taber, Katherine A., et al.
Publicado: (2018) -
Smith–Lemli–Opitz syndrome carrier frequency and estimates of in utero mortality rates
por: Lazarin, Gabriel A., et al.
Publicado: (2017) -
Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels
por: Lazarin, Gabriel A., et al.
Publicado: (2014)